Filing Details
- Accession Number:
- 0001237899-14-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-13 16:03:32
- Reporting Period:
- 2014-02-11
- Filing Date:
- 2014-02-13
- Accepted Time:
- 2014-02-13 16:03:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226690 | George Yancopoulos | 777 Old Saw Mill River Road Tarrytown NY 10591 | President Regeneron Laboratori | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-11 | 189,463 | $9.49 | 1,257,806 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-11 | 5,720 | $314.31 | 1,252,086 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-02-11 | 94,756 | $314.31 | 1,157,330 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-02-12 | 4,322 | $317.82 | 1,153,008 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 15,816 | $318.52 | 1,137,192 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 30,858 | $319.44 | 1,106,334 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 17,274 | $320.48 | 1,089,060 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 8,021 | $321.48 | 1,081,039 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 3,874 | $322.34 | 1,077,165 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 1,490 | $323.42 | 1,075,675 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 1,700 | $324.61 | 1,073,975 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 1,932 | $325.44 | 1,072,043 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 2,100 | $326.36 | 1,069,943 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 600 | $327.88 | 1,069,343 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 1,000 | $328.50 | 1,068,343 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-11 | 189,463 | $0.00 | 189,463 | $9.49 |
Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2014-02-11 | 5,720 | $0.00 | 5,720 | $314.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-12-15 | No | 4 | M | Direct | |
5,720 | 2014-08-11 | 2014-12-15 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,623 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 4,322 shares of Company stock on February 12, 2014 at prices ranging from $317.70 to $317.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 15,816 shares of Company stock on February 12, 2014 at prices ranging from $318.00 to $318.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 30,858 shares of Company stock on February 12, 2014 at prices ranging from $319.00 to $319.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 17,274 shares of Company stock on February 12, 2014 at prices ranging from $320.00 to $320.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 8,021 shares of Company stock on February 12, 2014 at prices ranging from $321.00 to $321.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 3,874 shares of Company stock on February 12, 2014 at prices ranging from $322.18 to $322.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 1,490 shares of Company stock on February 12, 2014 at prices ranging from $323.00 to $323.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 1,700 shares of Company stock on February 12, 2014 at prices ranging from $324.50 to $324.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 1,932 shares of Company stock on February 12, 2014 at prices ranging from $325.10 to $325.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 2,100 shares of Company stock on February 12, 2014 at prices ranging from $326.00 to $326.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 1,000 shares of Company stock on February 12, 2014 at prices ranging from $328.17 to $328.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.